Bill Few Associates, Inc. Bristol Myers Squibb CO Transaction History
Bill Few Associates, Inc.
- $305 Million
- Q2 2025
A detailed history of Bill Few Associates, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bill Few Associates, Inc. holds 10,595 shares of BMY stock, worth $487,158. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,595
Previous 9,962
6.35%
Holding current value
$487,158
Previous $607,000
19.28%
% of portfolio
0.16%
Previous 0.22%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,730Shares Held
1.59BCall Options Held
26MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA191MShares$8.8 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.3 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.06 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...